Approval · Notice of Compliance 25686 · 2021
OPSUMIT: Notice of Compliance 25686
Issued April 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25686
- Date
- April 16, 2021
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the drug drug interaction information in the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPSUMIT | Not yet assigned | — |
Medicinal ingredients
- MACITENTAN 10 MG per TAB